Home Amines 841290-80-0
841290-80-0,MFCD09970820
Catalog No.:AA008GUJ

841290-80-0 | 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b]

Pack Size
Purity
Availability
Price(USD)
Quantity
  
2mg
98%
in stock  
$7.00   $5.00
- +
5mg
98%
in stock  
$9.00   $7.00
- +
10mg
98%
in stock  
$12.00   $8.00
- +
250mg
95%
in stock  
$62.00   $44.00
- +
1g
95%
in stock  
$145.00   $102.00
- +
5g
98%
in stock  
$347.00   $243.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA008GUJ
Chemical Name:
6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b]
CAS Number:
841290-80-0
Molecular Formula:
C22H23FN6O5
Molecular Weight:
470.4536
MDL Number:
MFCD09970820
SMILES:
COc1cc(Nc2ncc(c(n2)Nc2ccc3c(n2)NC(=O)C(O3)(C)C)F)cc(c1OC)OC
Properties
Computed Properties
 
Complexity:
691  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
7  
XLogP3:
3.1  

Literature

Title: Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase.

Journal: Journal of medicinal chemistry 20140508

Title: Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Journal: Journal of medicinal chemistry 20131024

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters 20130801

Title: Rational design of highly selective spleen tyrosine kinase inhibitors.

Journal: Journal of medicinal chemistry 20121213

Title: Discovery and development of spleen tyrosine kinase (SYK) inhibitors.

Journal: Journal of medicinal chemistry 20120426

Title: Comprehensive analysis of kinase inhibitor selectivity.

Journal: Nature biotechnology 20111030

Title: Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures.

Journal: Protein science : a publication of the Protein Society 20110201

Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.

Journal: Chemistry & biology 20101124

Title: Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes.

Journal: Chemical biology & drug design 20090401

Title: Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20090401

Title: Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing.

Journal: Birth defects research. Part A, Clinical and molecular teratology 20090201

Title: R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.

Journal: The Journal of pharmacology and experimental therapeutics 20061201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:841290-80-0 Molecular Formula|841290-80-0 MDL|841290-80-0 SMILES|841290-80-0 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b]